Business
-
The US Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) has awarded a $4.4 million contract to Texas-based Southwest Research Institute (SwRI), an independent applied research and development organization, for… Read more . . .
-
During its presentation at the 2011 Morgan Stanley Global Healthcare Conference on September 14, Sun Pharma Advanced Research Company (SPARC) provided a detailed report on the development of its Starhaler dry powder inhaler and announced… Read more . . .
-
Just prior to a scheduled hearing to determine sanctions in the Proveris Scientic vs. InnovaSystems case that was scheduled for September 6, 2011, InnovaSystems filed for bankruptcy, indefinitely delaying the hearing. The petition for Chapter… Read more . . .
-
First quarter sales of Hi-Tech Pharmacal’s fluticasone proprionate nasal spray rose from $11,700,000 in 2010 to $26,200,000 this year, the company has announced, continuing a rapid increase in sales since the product was introduced. First… Read more . . .
-
Freeman Technology has moved to a new, larger facility in the Tewkesbury Business Park in Gloucestershire, UK. The new building includes office, laboratory, and manufacturing areas; additional space for expansion is available. Freeman has been… Read more . . .
-
On September 5, a ceremony in Tehran marked the occasion as Iran officially phased out CFC-based metered dose inhalers (MDIs) in accordance with the Montreal Protocol, becoming the first country in the Asia-Pacific region to… Read more . . .
-
UK drug delivery device company Bespak, a division of Consort Medical, says that it will develop a nasal delivery device “for a major unnamed global pharmaceutical company.” The contract, Bespak’s first for a nasal device,… Read more . . .
-
According to the FDA’s latest update on the ongoing acetylcysteine inhalation solution shortage, all of American Regent/Luitpold’s product is still on back order due to “manufacturing delays,” and the company is still unable to estimate… Read more . . .
-
The United States Court of Appeals has upheld a patent for Fortical calcitonin nasal spray held by Unigene Laboratories. Fortical, a bioequivalent of Novartis’s Miacalcin, is marketed in the US by Unigene subsidiary Upsher-Smith for… Read more . . .
-
Aegis Therapeutics has received US Patent No. 7,998,927 for stabilized formulations of GLP-1 peptide analogs that can be delivered by a variety of different routes, including intranasal. All currently available GLP-1 formulations, which can control… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland